Pipeline

Pipeline

HanBio’s pipeline spans dermal papilla cell therapies, DPC-derived exosome research, stem cell programs, NK cell programs, cosmetics ingredients, and companion-animal cell applications. The lead program is HXF-101, an autologous DPC-based candidate for androgenetic alopecia.

ProgramPlatformIndication / AreaStage
HXF-101Autologous DPCAndrogenetic alopeciaPreclinical / IND-enabling
HXF-102Allogeneic DPCHair lossProcess development / preclinical
HXF-201DPC ExosomeAlopecia researchBasic research / process development
HXC-101DPC Culture MediumHair / scalp cosmetic ingredientSafety / registration-related work
HXM-101MSCRegenerative applicationsBasic research
HXN-101NK CellImmune cell applicationsBasic research
HXA-101 / HXA-201Animal Cell TherapyCompanion animal applicationsProcess development / research
Scroll to Top
Call Now Button